Longevity Blogs

Coronary artery disease often advances for years without chest pain or another obvious warning. A coronary artery calcium scan can reveal one trace of that hidden process: calcium embedded within plaque in the walls of the heart's arteries.

The thymus has long been viewed as an immune organ that fades into retirement after childhood. A new Nature study using AI and chest CT scans suggests that healthier-looking adult thymic tissue is associated with longer survival and lower risks of lung cancer and cardiovascular death—but the findings remain observational.

Imagine that aging is a building occupied by twelve vandals. Through some triumph of future medicine, eleven are escorted out. Telomeres behave, mitochondria stop sulking, inflammation lowers its voice, and senescent cells finally leave the party.

Heart disease rarely comes from a single broken switch. It usually develops through several interacting problems: blood pressure, cholesterol, smoking, blood-sugar control, body composition, inflammation, genetics, and time. A 2025 study asked whether combining two of those signals, inflammation and insulin resistance, might reveal cardiovascular risk more clearly than looking at either one alone [1].

Uric acid has a public-relations problem. Most people meet it through gout, kidney stones, or a laboratory result their doctor wants to lower. Yet uric acid is also one of the most abundant antioxidants circulating in human blood.

Coffee headlines tend to arrive with the confidence of a barista calling out an order: three cups are good, five cups are bad, and your genes decide the rest. The real evidence is more interesting and less tidy. Two large UK Biobank studies found that moderate coffee intake was associated with lower risks at several stages of chronic disease, while one of them also found higher risks among people drinking more than five cups a day.

Childhood adversity might set the stage for accelerated aging, but it doesn’t act alone. The pace at which someone ages—biologically, not just chronologically—is shaped by a mix of internal biology and external environment. And while some of those effects make things worse, others open the door for healing.

What happens in childhood doesn’t stay in childhood at the cellular level, anyway. People who grow up in environments marked by trauma, neglect, or family dysfunction are more likely to face serious health challenges decades later, from heart disease and diabetes to depression and early death. This isn’t just a pattern seen in anecdotes, it’s a well-documented public health crisis.

Start with the tiny pink, blue, yellow, or fashionably minimalist packet. It looks harmless enough, the sort of thing that lives next to diner coffee and asks only to be ignored. Then a Neurology paper comes along and suggests that higher long-term intake of several low- and no-calorie sweeteners was associated with faster cognitive decline.

The compound that makes tomatoes red has attracted attention far beyond the produce aisle. Lycopene is a carotenoid, a family of plant pigments that includes several substances with antioxidant activity. In laboratory research, lycopene has shown intriguing effects in models of brain injury, including models designed to imitate selected features of Parkinson's disease.

Aging biology has a wonderfully unfair habit: just when you think the plot is about genes, stem cells, or mitochondria, it points to something duller and more physical, like old proteins quietly getting chemically scuffed. The new Nature Communications paper from Trabosh and colleagues is about exactly that sort of damage, and its central claim is preliminary but genuinely interesting: an engineered enzyme called CMLase can remove a common aging-related protein modification called N-epsilon-carboxymethyl-lysine, or CML, from model proteins and from aged human tissue samples outside the body [1]. That is not the same as rejuvenating a person.

At 25, it can feel as though the brain forgives almost anything: a bad night of sleep, a punishing deadline, skipped meals, or a week lived on adrenaline. Recovery often comes quickly enough that the cost remains easy to ignore. After 40, many people notice that the margin is smaller. A stressful week lingers. Sleep disruption produces more brain fog. Irritability appears sooner, and concentration takes longer to return. There is real biology behind that experience, but there is no switch that flips on your fortieth birthday. Stress affects the brain across the entire lifespan, and its effects depend on intensity, duration, genetics, health, sleep, exercise, and previous adversity [1].

Search for sermorelin online and you will quickly find a familiar promise: better sleep, more muscle, less fat, faster recovery, sharper thinking, and perhaps even slower aging. The appeal is obvious. Sermorelin is often described as a gentler, more “natural” alternative to human growth hormone because it asks the body to release more of its own hormone rather than supplying growth hormone directly. That description contains real physiology. It also leaves out important facts. Sermorelin has legitimate medical history, but much of today’s anti-aging marketing reaches beyond the evidence. It is best understood as a short biological signal whose effects depend on the pituitary gland, the patient, and the reason it is prescribed.

Anxiety has been medicalized, therapized, supplemented, branded, and turned into a category of its own. And still it keeps showing up in bodies, homes, offices, marriages, inboxes, and sleepless nights. The National Institute of Mental Health estimates that 19.1% of U.S. adults experience an anxiety disorder in a given year, and 31.1% experience one at some point in life [1]. That does not mean everyone is sick. It means anxiety is common enough that we need a better map.

Every few years, the wellness world finds a molecule and hands it a cape. Not a modest cardigan. A cape, flapping while someone on a podcast says “regeneration” like it is a sacrament. BPC-157 is one of those molecules. It is often called the “Wolverine peptide,” a warning sign because biology is not a Marvel franchise. The claim is seductive: faster tendon healing, calmer guts, less pain. Wonderful. Also: hold the parade. BPC-157 stands for Body Protection Compound-157. It is a short chain of amino acids, originally studied as a stable gastric pentadecapeptide - a 15-amino-acid fragment associated with stomach-related biology

Sorghum is not the first grain most people think of when they hear about brain health. Oats, blueberries, olive oil, and leafy greens usually get more attention. But sorghum, especially darker pigmented varieties, is starting to interest researchers because it contains a rich mix of plant polyphenols—compounds that can influence oxidative stress, inflammation, metabolism, and cell signaling.

Magnesium has always had a quiet, behind-the-scenes job in the body. It helps nerves communicate, muscles contract, blood pressure stay regulated, and hundreds of enzymes do their work [1]. So it is not surprising that supplement makers, researchers, and consumers have wondered whether magnesium might also matter for the brain. A new randomized clinical trial adds an interesting piece to that puzzle: in adults with poor sleep, six weeks of magnesium L-threonate, sold under the ingredient name Magtein, was linked with better scores on some cognitive tests and an estimated 7.5-year improvement in cognitive age compared with placebo [2].

A diabetes medicine has become one of the more interesting side stories in aging research. The drugs are called SGLT2 inhibitors, a mouthful of a name for medicines such as empagliflozin, dapagliflozin, and canagliflozin. They were first developed to help people with type 2 diabetes lower blood sugar. More recently, doctors have learned that some of these drugs can also protect the heart and kidneys. Now researchers are asking a newer question: could they also calm some of the cellular wear-and-tear linked with aging? A 2025 review in npj Aging argues that the idea is scientifically plausible, but still early [1].

Alzheimer's disease is usually discussed in terms of sticky amyloid plaques, tangled tau proteins, and the slow loss of memory. Those pieces still matter. But a new study adds another layer to the story: the way brain cells decorate proteins with sugar-based molecules. In a 2026 Nature Metabolism paper, researchers reported that brains affected by Alzheimer's disease showed unusually high levels of a process called glycosylation, and that pushing this process up or down changed memory-related behavior in mouse models [1].

Every cell in your body is a talker. Some cells communicate with electrical pulses, some with hormones, and many with tiny packages called extracellular vesicles, or EVs. Think of EVs as sealed envelopes released by cells into the fluid around them. Inside the envelope may be proteins, fats, pieces of genetic material, or chemical signals. Other cells can pick up these packages and change their behavior in response. That is useful when the message says, in effect, repair this tissue or calm this inflammation. It can be harmful when the message spreads stress, inflammation, or damaged cell parts.

A gene variant linked to long life may help nerve cells stay younger by doing something very practical: keeping their DNA in better shape. A 2026 study in Aging Cell examined APOE2, a version of the APOE gene that has long been associated with lower Alzheimer's disease risk and exceptional longevity. The researchers found that human neurons carrying APOE2 showed stronger signs of DNA repair activity, less DNA damage, and more resistance to stress-induced cellular senescence than neurons carrying APOE4, the best-known genetic risk factor for late-onset Alzheimer's disease [1].

Picture the standard birthday ritual. Cake. Candles. Someone sings slightly off-key. You blow out the flames and, according to the usual story, become exactly one year older in a smooth, orderly, bureaucratically approved fashion. Biology, unfortunately, appears not to have read the handbook. Aging is often described as a steady downhill slope: a little more wear each year, a little less repair, repeat until the machinery starts making suspicious noises. But a 2024 study in Nature Aging suggests that some parts of biology behave more like a badly maintained mountain road—modest stretches interrupted by curves and jolts.

Imagine telling a tired old eye cell, “Listen, I am not asking you to become a baby cell again. Please do not throw a developmental tantrum. Just remember how to do your job.” That, in plain English, is the ambition behind partial reprogramming. And now, for the first time, that idea has moved from mouse papers, conference buzz, and biotech optimism into a human eye trial. The trial number is NCT07290244.

Artificial intelligence is not making aging disappear. Let's get that out of the way before the immortality kazoo parade starts honking its way down the hallway and somebody in a Patagonia vest tells you that death has been disrupted. It has not. Biology remains stubborn, damp, mutinous, and very fond of humiliating clean business plans. But AI is doing something real in longevity science: it is becoming a ferociously fast pattern-finder, the sort of tool that can rummage through genes, proteins, blood markers, medical records, imaging, drug structures, clinical trials, and wearable-device signals without needing coffee, tenure, or a sabbatical.

Most people think of DNA damage as a cancer problem. That is true, but it is only part of the story. DNA damage also sits near the center of aging biology because every cell has to keep its genetic instruction manual readable while dealing with sunlight, inflammation, metabolism, toxins, and ordinary wear from daily life. The new excitement around the DREAM complex comes from a simple but powerful idea: what if some cells age faster partly because their DNA-repair tools are being held back?

Nattokinase sounds like a lab-made drug, but it starts in a very ordinary place: natto, the sticky fermented soybean food popular in Japan. During fermentation, Bacillus subtilis var. natto produces an enzyme that can break down fibrin, one of the protein threads that helps blood clots hold together. That basic fact explains why nattokinase has attracted so much attention for heart and blood-vessel health. It also explains why the claims around it need careful handling. An enzyme that nudges clotting biology is not the same thing as a proven replacement for aspirin, statins, blood-pressure medicine, or anticoagulants

Most of us think about the body clock in ordinary terms: sleep, jet lag, late-night snacks, and the misery of daylight saving time. A 2026 Cell study takes that familiar idea into much deeper territory. Researchers reported that timed treatment with 3'-deoxyadenosine, also called 3dA or cordycepin, strengthened circadian rhythm amplitude in a small hypothalamic brain region called the paraventricular nucleus, or PVN. In aged male mice, that intervention improved several aging-related measures, reduced DNA-methylation age, restored hormonal synchrony, and extended lifespan

A 100-year-old immune system is not a brand-new immune system. It has seen decades of viruses, vaccines, injuries, stress, meals, sleep cycles, and ordinary wear and tear. What makes centenarians so interesting is that many of them seem to reach very old age without the immune system tipping as far into dysfunction as we might expect. A 2026 review in Nature Reviews Immunology describes this as a long-lived immune system: not perfectly youthful, but unusually good at preserving balance, resisting disease, and avoiding some of the worst effects of chronic inflammation

For years, the standard answer about human lifespan has been fairly modest: genes matter, but not as much as people think. Classic twin studies often put the heritability of longevity around 20% to 25%, and a huge family-tree analysis later suggested the genetic contribution might be even lower, partly because families share culture, wealth, geography, habits, and spouse choices as well as DNA [1,2]. Then a 2026 Science paper reopened the argument with a much bigger number. After correcting for what the authors call extrinsic mortality, they estimated that the heritability of intrinsic human lifespan is above 50%

Vitamin C has been around the wellness world so long that it almost feels boring. People associate it with oranges, immune support, and avoiding scurvy. So it was surprising when a 2026 Cell Metabolism study put vitamin C into a much more modern aging-science story. The researchers proposed a new aging pathway they called "ferro-aging," centered on iron buildup, lipid damage, and an enzyme called ACSL4. Even more attention-grabbing, they reported that long-term vitamin C treatment in aged monkeys reduced several ferro-aging signatures, improved some neurological and metabolic measures, and shifted multi-omic aging clocks in a younger direction

Let us begin with the fantasy, because the fantasy is doing most of the work here. You are tired. Your sleep is lousy. The gym used to reward you for showing up, and now it behaves like a bureaucrat who lost your paperwork. Then along comes sermorelin, a tidy little peptide with a lab-coat name and a seductive promise: nudge your pituitary, raise growth hormone, bring back some of the old biological swagger. Terrific. Also, hold on to your wallet and maybe your endocrine system.

Imagine if scientists could make your cells younger without changing a single letter of your genetic code. It sounds like science fiction, but researchers have developed a revolutionary tool that does exactly that. Using a modified version of CRISPR—the gene-editing technology that won the Nobel Prize—scientists can now edit the "software" of your cells without touching the genetic "hardware." And early results suggest this approach might actually reverse aging.

Everyone knows smoking causes cancer and lung disease. But recent research reveals something equally troubling: smoking literally makes your body age faster at the cellular level. Scientists have discovered exactly how cigarettes accelerate the biological clock ticking inside every cell in your body—and the mechanism is more fascinating than you might expect.

When you plunge into cold water, your body triggers a remarkable family of protective proteins led by RBM3 that can repair brain synapses, fight neurodegeneration, and may hold keys to living longer and thinking sharper.

Your body already makes creatine. Your muscles already run on it. And yet, taken in supplemental form, this small nitrogen-containing molecule has accumulated one of the most robust evidence bases in the history of nutritional science

If you hear the word “polyphenols” and immediately think “superfood marketing,” that reaction is fair. The term gets tossed around so often that it can sound like nutritional confetti. But polyphenols are real, and they matter. They are a large family of compounds made by plants, and they show up in foods many people already eat: berries, cocoa, tea, coffee, olives, extra-virgin olive oil, grapes, apples, onions, herbs, and many vegetables [1]. The honest question is not whether polyphenols exist or whether they can do interesting things in a lab. The real question is whether they help people live longer or age better.

Rapamycin, or sirolimus, has become one of the central drugs in the modern biology-of-aging conversation. The reason is simple: in animal studies it has repeatedly extended lifespan and improved several measures of late-life function, which is rare enough to command attention. That track record is why rapamycin moved from an interesting laboratory result to a serious human research question. The question now is not whether mTOR signaling matters in aging. It plainly does. The question is whether manipulating that pathway in people can improve healthspan in a way that is clinically meaningful and safe. Human evidence, as of May 4, 2026, is still early and mixed, but it is no longer speculative

Your immune system is basically a paranoid security guard, constantly patrolling your body and demanding to see everyone's credentials. Most of the time, this works beautifully—infected cells get escorted out, abnormal cells get eliminated, and you stay healthy.

By David Haines, Ph.D.

Edited and approved by Stephen C. Rose, Ph.D.

Senolytic drugs, partial cellular reprogramming, and AI-enabled precision medicine are among the most promising technologies under development in the longevity space. The first two have produced notable results in animal studies....

Edited and approved by Stephen C. Rose, Ph.D.

Retiring well is less about hitting a ceremonial age and more about protecting the conditions that support long-term health. Research on retirement and aging suggests that timing, structure, purpose, social connection, physical activity, sleep, and the...

By Donna Wrigh

Edited and approved by Stephen C. Rose, Ph.D.

If you are carrying around an old grudge, you probably do not need anyone to tell you it takes up space. A painful statement, breach of trust, or deep disappointment may have happened once, but the mind has a way of bringing it back into...

by Donna Wright

Edited and approved by Stephen C. Rose, Ph.D.

Consider the Benefits of Pet Ownership on Longevity

Picture a dog at 6:12 on a cold, wet morning, staring at you with the moral authority of a federal judge. You foolishly imagined you were going to savor your morning coffee in a peaceful...

By David Haines, Ph.D.

Edited and approved by Stephen C. Rose, Ph.D.

The journey to a longer life and a longer healthspan does not begin with supplement stacks, hacks, or optimization theater. It points toward avoiding a familiar set of high-impact risks. Across cohort studies, combinations of...